Download Free Sample Report

The global Intravenous (IV) Iron Drugs market was valued at US$ 1472.2 million in 2022 and is projected to reach US$ 1925.2 million by 2029, at a CAGR of 3.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report aims to provide a comprehensive presentation of the global market for Intravenous (IV) Iron Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous (IV) Iron Drugs. This report contains market size and forecasts of Intravenous (IV) Iron Drugs in global, including the following market information:

• Global Intravenous (IV) Iron Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
• Global Intravenous (IV) Iron Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
• Global top five Intravenous (IV) Iron Drugs companies in 2022 (%)

The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Ferric Carboxymaltose Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Intravenous (IV) Iron Drugs include Sanofi US, Allergan, AMAG Pharmaceuticals, Dalichi Sankyo, Luitpold Pharmaceuticals, Pharmacosmos and Takeda Pharmaceutical, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Intravenous (IV) Iron Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Intravenous (IV) Iron Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Intravenous (IV) Iron Drugs Market Segment Percentages, by Type, 2022 (%)

• Ferric Carboxymaltose
• Iron Sucrose
• Iron Dextran
• Others

Global Intravenous (IV) Iron Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Intravenous (IV) Iron Drugs Market Segment Percentages, by Application, 2022 (%)

• Nephrology
• Gynecology & Obstetrics
• Gastroenterology
• Oncology
• Cardiology
• Others

Global Intravenous (IV) Iron Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Intravenous (IV) Iron Drugs Market Segment Percentages, By Region and Country, 2022 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Intravenous (IV) Iron Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Intravenous (IV) Iron Drugs revenues share in global market, 2022 (%)
Key companies Intravenous (IV) Iron Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Intravenous (IV) Iron Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:

• Sanofi US
• Allergan
• AMAG Pharmaceuticals
• Dalichi Sankyo
• Luitpold Pharmaceuticals
• Pharmacosmos
• Takeda Pharmaceutical

Outline of Major Chapters:

• Chapter 1: Introduces the definition of Intravenous (IV) Iron Drugs, market overview.
• Chapter 2: Global Intravenous (IV) Iron Drugs market size in revenue and volume.
• Chapter 3: Detailed analysis of Intravenous (IV) Iron Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
• Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
• Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
• Chapter 6: Sales of Intravenous (IV) Iron Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
• Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
• Chapter 8: Global Intravenous (IV) Iron Drugs capacity by region & country.
• Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
• Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
• Chapter 11: The main points and conclusions of the report.